Yahoo! Fresenius' Pilot-Study News Good, Not Bad, for Affy

Affymax Inc.'s morning Wall Street sell-off reversed itself by the afternoon on Thursday, as shareholders began to understand what the decision by dialysis firm Fresenius Medical Care North America – in contract negotiations with Affymax – really meant.